Urology Practice Management - December 2015, Vol 4, No 6

Genomic Test Supports Treatment Decisions in Prostate Cancer
A genomic classifier is now available that can predict a low or high risk for metastasis in men with prostate cancer who have rising prostate-specific antigen (PSA) after a prostatectomy. The good news is that this test is reimbursable by Medicare. Read More ›

New Prostate Cancer Biomarkers Can Predict Aggressive Disease in African Americans
It is well-known that African-American men have a higher incidence of prostate cancer and a greater mortality rate than American men of other races and ethnicities. Read More ›

Healthcare is among the top economic and social problems across the globe in terms of patient access to care and affordability. Read More ›

The Centers for Medicare & Medicaid Services (CMS) Office of Minority Health has released a 19-page plan to address health equity gaps for underserved Medicare beneficiaries, improve their access to care, and measure the success of this undertaking. Read More ›

In the era of personalized medicine, identifying patients with cancer who will benefit most from a specific treatment is the Holy Grail. Currently, there is no test to identify effective chemotherapy before administering treatment. Read More ›

It is valid to predict survival using tumor stage after neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC), said Peter Black, MD, Senior Research Scientist, Vancouver Prostate Centre, British Columbia, Canada. Read More ›

African Americans in urology are very slowly increasing in numbers and prominence, helped by networking and mentorship and through associations for African-American physicians, according to some senior African- American urologists. Read More ›

Inventive Korean researchers are testing an app that plays the sound of running water to help men with lower urinary tract symptoms (LUTS) to “let go and let it flow.” Read More ›

What does a Health Insurance Portability and Accountability Act (HIPAA)-related “incident response” mean to your organization and your oncology practice? Read More ›

Philanthropic individuals can contribute a wide variety of assets to charity. In addition to the social good that comes with the contribution, there may also be a financial benefit to the donor through an income tax charitable deduction for the charitable gift. Read More ›

Subscribe to
Urology Practice Management

Stay up to date with urology news & updates by subscribing to recieve the free UPM print publications or weekly e‑Newsletter.

I'd like to recieve: